| Clade2.3.2 H5N1亚型禽流感疫苗候选株的构建 |
| |
| 引用本文： | 张妍,张文俊,李群辉,刘晓文,刘文博,刘秀梵.Clade2.3.2 H5N1亚型禽流感疫苗候选株的构建[J].畜牧兽医学报,2012,43(6):915-921. |
| |
| 作者姓名： | 张妍 张文俊 李群辉 刘晓文 刘文博 刘秀梵 |
| |
| 作者单位： | 扬州大学兽医学院农业部畜禽传染病学重点开放实验室,扬州,225009 |
| |
| 基金项目： | 现代农业产业技术体系建设专项资金，国家重点基础研究发展计划(973计划) |
| |
| 摘 要： | 近年来Clade2.3.2H5N1亚型的禽流感病毒逐渐成为我国及越南等其他一些国家流行的优势毒株,并呈现出一定变化规律的氨基酸进化趋势。本研究以A/Puerto Rico/8/34(H1N1)(PR8)AIV为内部基因供体,以Clade2.3.2H5N1亚型AIV A/chicken/Yangzhou/1117/2011(YZC3)为表面抗原血凝素(HA)和神经氨酸酶(NA)基因供体,通过反向遗传操作,在符合人类疫苗生产标准的COS-1细胞中救获低致病性的疫苗毒株。结果成功拯救出1株重组病毒rYZC3,该病毒在鸡胚和MDCK细胞上均具有较好的繁殖能力,对SPF鸡和鸡胚无致病性。本研究为防控当代流行的H5亚型禽流感提供了良好的疫苗候选株。
|
| 关 键 词： | H5亚型 Clade2.3.2 禽流感病毒 反向遗传 |
Generation of Clade 2.3.2 H5N1 Subtype Avian Influenza Vaccine Candidate |
| |
| ZHANG Yan
,
ZHANG Wen-jun
,
LI Qun-hui
,
LIU Xiao-wen
,
LIU Wen-bo
,
LIU Xiu-fan.Generation of Clade 2.3.2 H5N1 Subtype Avian Influenza Vaccine Candidate[J].Acta Veterinaria et Zootechnica Sinica,2012,43(6):915-921. |
| |
| Authors: | ZHANG Yan ZHANG Wen-jun LI Qun-hui LIU Xiao-wen LIU Wen-bo LIU Xiu-fan |
| |
| Institution: | *(Key Laboratory of Animal Infectious Diseases of Ministry of Agriculture,Yangzhou University, Yangzhou 225009,China) |
| |
| Abstract: | Currently,H5N1 viruses in Clade 2.3.2 are predominant viruses which prevail in China and other countries,and occurrence of a certain evolutionary trends of amino acid changes.In this report,a reassortant virus containing the HA and NA genes from an new isolate A/chicken /Yangzhou/1117/2011(YZC3) and the backbone A/Puerto Rico/8/34(H1N1)(PR8) strain were constructed.The virus was rescued from the COS-1 cell line and prepared as inactivated whole-virus vaccine.Vaccine virus was avirulent to SPF chickens and embryonated chicken eggs,replicating well in eggs and MDCK cells.The results indicate that the reassortant viruses is suitable for vaccine manufacturing and being used as reference vaccine virus against the H5N1 Clade 2.3.2 viruses. |
| |
| Keywords: | H5 Clade2 3 2 avian influenza virus reverse genetics |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
|
